Sexual risk behaviour of Canadian participants in the first efficacy trial of a preventive HIV-1 vaccine
- drug therapy in HIV infection. Ree, Hugo // HIV Australia;Apr2003, Vol. 2 Issue 3, p25
Presents a roundup of the Sixth International Congress on Drug Therapy in HIV Infection held in Glasgow, Scotland in 2002. Discussion on structured treatment interruptions that were raised with an update by Patrick Yeni from France; Vaccine news; Goal of antiviral therapy.
- Measuring HIV-1-Specific T Cell Immunity: How Valid Are Current Assays? Patricia D'Souza, M.; Altfeld, Marcus // Journal of Infectious Diseases;2/1/2008, Vol. 197 Issue 3, p337
The authors reflect on the validity of the current assays of HIV-1-Specific T Cell Immunity vaccines. The author believes that the development of an effective HIV-1 vaccine to prevent virus transmission or stop the progression of the disease is a major challenge in biomedical research. They also...
- Determinants of personal demand for an AIDS vaccine in Uganda: contingent valuation survey. Bishai, David; Pariyo, George; Ainsworth, Martha; Hill, Kenneth // Bulletin of the World Health Organization;Sep2004, Vol. 82 Issue 9, p652
Objective To assess the factors affecting demand for an HIV/AIDS vaccine among adults in their prime earning and childbearing years and the impact of vaccination on risk behaviour in a high-prevalence, low-income country. Methods A contingent valuation survey of 1677 adults aged 18-60 years was...
- Meeting Reporter. // Patient Care;Oct2004, Vol. 38 Issue 10, p17
Provides information on the AIDS Vaccine Conference held in 2004. Estimates of the number of HIV infections by 2010; Shift in the direction of AIDS vaccine research; Importance of collaborative efforts to accelerate the progress of promising vaccines.
- Cognitive Executive Functioning in Relation to HIV Medication Adherence Among Gay, Bisexual, and other Men who have Sex with Men. Solomon, Todd M.; Halkitis, Perry N. // AIDS & Behavior;Jan2008, Vol. 12 Issue 1, p68
A longitudinal study of 300 HIV-positive gay, bisexual or non-gay-identified men-who-have-sex-with-men was undertaken to consider patterns relating to HIV medication adherence. The purpose of our analyses was to consider the rate of adherence in relation to both age and executive functioning as...
- nature insight AIDS. Weiss, Ursula // Nature;4/19/2001, Vol. 410 Issue 6831, p961
Introduces the topic of HIV/AIDS for the Nature Insight section of the issue. Worldwide prevalence and spread of AIDS; Need for a vaccine to prevent AIDS and medicine to treat those already infected; Details of the articles in the section, including the mechanisms of AIDS and chemotherapy for AIDS.
- THE QUEST FOR A PREVENTIVE VACCINE AGAINST HIV/AIDS. Esparza, José // Vaccines: Preventing Disease & Protecting Health;2004, p189
Information on the efforts to develop a preventive vaccine against HIV/AIDS in the U.S. from a chapter of the book "Vaccines: Preventing Disease and Protecting Health" is presented. It traces the history of HIV/AIDS. It discusses the challenges associated with the efforts to develop HIV vaccine,...
- HIV aÅŸÄ±sÄ±. Yarpuzlu, Aysegul Akbay // Turkish Journal of Biochemistry / Turk Biyokimya Dergisi;Sep2011, Vol. 36 Issue 3, p273
An HIV vaccine is a hypothetical vaccine against HIV, the etiological agent of AIDS. As there is no known cure for AIDS, the search for a vaccine has become part of the struggle against the disease. An HIV vaccine is generally considered as the most likely, and perhaps the only way by which the...
- The quest for the AIDS vaccine. Tonks, Alison // BMJ: British Medical Journal (International Edition);6/30/2007, Vol. 334 Issue 7608, p1346
The article focuses on problems researchers are facing in 2007 when attempting to discover a vaccine for AIDS. Arguments are presented which suggest that finding vaccines for the disease are difficult because HIV is one of the most complex viruses ever identified and is extremely good at evading...